Prenatal and Newborn Genetic Testing Market to Reach US$ 11,204.74 Mn at CAGR of 12.2% in 2027 | The Insight Partners

Prenatal and Newborn Genetic Testing Market to 2027 - Global Analysis and Forecasts By Product (Diagnostic, and Screening), Disease (Cystic Fibrosis, Sickle Cell Anemia, Downs Syndrome, Phenylketonuria, and Other Disease), End User (Hospitals and Clinics, Diagnostic Centers, and Other End User) and Geography

Publication Month: Jul 2019 | Report Code: TIPBT00002550 | No. of Pages: 194 | Category: Biotechnology | Status: Published

The global prenatal and newborn genetic testing market accounted to US$ 4,034.37 Mn in 2018 and is expected to grow at a CAGR of 12.2% during the forecast period 2019 - 2027, to account to US$ 11,204.74 Mn by 2027.

 

The Asia Pacific region market is the leading and the largest market among all regions and is expected to grow with CAGR of 12.8%. The growth in the region is driven by the key factors such as embodiment of favorable reimbursement policies for prenatal and newborn screens by Japanese insurance providers, the high fertility rate in the region, and new government initiatives that support prenatal and newborn screening activities for pregnant females and infants in the region. In addition, rapidly developing healthcare infrastructure, and the presence of leading competitors in the region are also some of the factors contributing to the market growth.

 

Exhibit: Lucrative Regional Prenatal & Newborn Genetic Testing Markets

 

Market Insights

High Prevalence of Genetic Diseases in Infants

Several types of genetic diseases affect the fetuses in the womb. The way in which these genetic diseases are inherited helps to determine the risk that they pose on pregnancy as well as the risk of its recurrence. The risk of having genetic diseases in babies is high in cases where the parents have another child with a genetic disease, family history of a genetic disorder, or if either of a parent has a chromosomal abnormality. There is a significant prevalence of genetic diseases among infants. Moreover, these diseases are also responsible for infant mortality across the globe. For instance, according to the World Health Organization 2016, an estimated 7.9 million infants across the world are born with genetic defects. Moreover, according to the Centers for Disease Control and Prevention (CDC), birth defects affects every 1 in 33 babies born in the US. On the other hand, chromosomal abnormalities such as Down syndrome affects 1 in 691 babies born in the US, as per the CDC’s data in 2017.

 

Thus, the high prevalence of genetic diseases among infants account for the increasing demands for prenatal and newborn genetic tests, thereby contributing to the growth of the market.

 

Emerging Markets in Developing Countries

The emerging markets in the developing countries in the Asia Pacific region are creating better opportunities for the major market players to expand their business. This is a major reason for the market growth in the forecast period. Most of the major players focus on emerging markets such as India, China, and others. As they have a large number of population and technological advancements in these countries also favor the growth of the market.

 

Furthermore, the growing healthcare sector in this region is likely to enhance the growth opportunities for the prenatal and newborn genetic testing market. For instance, the increasing number of corporate hospitals like Apollo group, Max, Fortis, and others in India is likely increasing professionalism as well as lead to the emergence of the latest medical technology. Max Healthcare offers the prenatal test in India in order to identify as well as prevent the permanent disability in the newborn.

 

Thus, growing population in emerging countries and advanced healthcare sector in the region is likely to boost the market and is expected to provide significant growth opportunities to the players operating in the market during the forecast period.

 

Product Insights

Based on product, the global prenatal and newborn genetic testing market was segmented into screening and diagnostics. In 2018, the screening segment held the largest market share of 59.1% of the prenatal and newborn genetic testing market, by product. Moreover, the same segment is also expected to witness the highest CAGR over the coming years owing to the factors such as increasing number of pregnant females adopting prenatal screening, increased mandatory regulations for newborn screening tests and others. Moreover, screens are the first line tests that pregnant women and newborn undergoes that also adds up to the major share of the market and its dominance in the global market.

 

Exhibit: Prenatal and newborn genetic testing market, by Product

 

Strategic Insights

Product launches, partnerships, and acquisitions were observed as the most adopted strategy in global prenatal and newborn genetic testing market industry. For instance, in June 2019, Illumina introduced VeriSeq NIPT Solution v2, a CE-IVD, next-generation sequencing (NGS)-based approach to noninvasive prenatal testing (NIPT). The comprehensive automated solution allows laboratories to screen for a broader range of chromosomal and sub-chromosomal conditions associated with birth defects and adverse pregnancy outcomes than the standard NIPT menu. Moreover, in April 2019, Abbott acquired Alere, a diagnostic device and service provider for $5.3 billion. Alere offers products like Alere Actim PROM, a test which used to diagnose the rupture of fetal membranes in pregnant women. Thus enhancing Abbott’s prenatal product portfolio.

 

PRENATAL AND NEWBORN GENETIC TESTING MARKET – MARKET SEGMENTATION

Global Prenatal and Newborn Genetic Testing Market – By Product

  • Diagnostic
    • Spectrophotometer
    • Polymerase Chain Reaction
    • Fluorescence in-situ Hybridization
    • Array-Comparative Genomic Hybridization
  • Screening
    • Maternal Serum Screening
    • Chronic Villus Sampling
    • Amniocentesis
    • Non-invasive Prenatal Testing

Global Prenatal and Newborn Genetic Testing Market – By Disease Indication

  • Cystic Fibrosis
  • Sickle Cell Anemia
  • Down Syndrome
  • Phenyketonuria
  • Other Diseases

 

Global Prenatal and Newborn Genetic Testing Market – By End User

  • Hospitals & Clinics
  • Diagnostic Centres
  • Other End Users

 

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
    • Spain
    • Italy
  • Asia Pacific (APAC)
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Middle East & Africa (MEA)
    • Saudi Arabia
    • South Africa
    • UAE
  • South America (SAM)
    • Brazil
    • Argentina

 

Company Profiles

  • Abbott
  • Quest Diagnostics Incorporated
  • Ravgen
  • Bio-Rad Laboratories, Inc.,
  • Illumina, Inc.
  • F. Hoffmann La-Roche Ltd.
  • Qiagen
  • Berry Gene
  • PerkinElmer, Inc.
  • Natera, Inc.
  • Laboratory Corporation of America Holdings (Sequenom)

1.             Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        Global Prenatal and Newborn Genetic Testing Market – By Product

1.3.2        Global Prenatal and Newborn Genetic Testing Market – By Disease Indication

1.3.3        Global Prenatal and Newborn Genetic Testing Market – By End User

1.3.4        Global Prenatal and Newborn Genetic Testing Market – By Geography

2.             Global Prenatal And Newborn Genetic Testing Market – Key Takeaways

3.             Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             Global Prenatal And Newborn Genetic Testing– Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1        North America – PEST Analysis

4.2.2        Europe – PEST Analysis

4.2.3        Asia Pacific – PEST Analysis

4.2.4        Middle East & Africa– PEST Analysis

4.2.5        South & Central America – PEST Analysis

5.             Global Prenatal And Newborn Genetic Testing Market –  Key Industry Dynamics

5.1       Key Market Drivers

5.1.1        High Prevalence of Genetic Diseases in Infants

5.1.2        Government Support to Promote Prenatal and Newborn Testing

5.1.3        Increasing Birth Rate

5.2       Key Market Restraints

5.2.1        Risks Associated with Prenatal Testing

5.3       Key Market Opportunities

5.3.1        Emerging Markets in Developing Countries

5.4       Future Trends

5.4.1        Digital Microfluidics Poses a New Opportunity Area for the Newborn Screening Market

5.5       Impact Analysis

6.             Prenatal And Newborn Genetic Testing Market –  Global Analysis

6.1       Global Prenatal And Newborn Genetic Testing Market Revenue Forecasts And Analysis

6.2       Global Prenatal And Newborn Genetic Testing Market, By Geography - Forecasts And Analysis

6.3       Performance of Key Players

6.3.1        F. Hoffmann La-Roche Ltd.

6.3.2        Laboratory Corporation of America Holdings (Sequenom)

6.3.3        PerkinElmer, Inc.

7.             Prenatal And Newborn Genetic Testing Market Analysis And Forecasts To 2027 – Product

7.1       Overview

7.2       Global Prenatal and Newborn Genetic Testing Market Share By Product 2018 & 2027 (%)

7.3       Diagnostic Market

7.3.1        Overview

7.3.2        Diagnostic Market Revenue and Forecast to 2027 (US$ Mn)

7.3.3        Spectrophotometer Market

7.3.3.1      Overview

7.3.3.2      Spectrophotometer Market Revenue and Forecast to 2027 (US$ Mn)

7.3.4        Polymerase Chain Reaction Market

7.3.4.1      Overview

7.3.4.2      Polymerase Chain Reaction Market Revenue and Forecast to 2027 (US$ Mn)

7.3.5        Fluorescence in-situ Hybridization Market

7.3.5.1      Overview

7.3.5.2      Fluorescence in-situ Hybridization Market Revenue and Forecast to 2027 (US$ Mn)

7.3.6        Array Comparative Genomic Hybridization Market

7.3.6.1      Overview

7.3.6.2      Array Comparative Genomic Hybridization Market Revenue and Forecast to 2027 (US$ Mn)

7.4       Screening Market

7.4.1        Overview

7.4.2        Screening Market Revenue and Forecast to 2027 (US$ Mn)

7.4.3        Maternal Serum Screening Market

7.4.3.1      Overview

7.4.3.2      Maternal Serum Screening Market Revenue and Forecast to 2027 (US$ Mn)

7.4.4        Chorionic Villus Sampling Market

7.4.4.1      Overview

7.4.4.2      Chorionic Villus Sampling Market Revenue and Forecast to 2027 (US$ Mn)

7.4.5        Amniocentesis Market

7.4.5.1      Overview

7.4.5.2      Amniocentesis Market Revenue and Forecast to 2027 (US$ Mn)

7.4.6        Non-Invasive Prenatal Testing Market

7.4.6.1      Overview

7.4.6.2      Non-Invasive Prenatal Testing Market Revenue and Forecast to 2027 (US$ Mn)

8.             Prenatal And Newborn Genetic Testing Market Analysis And Forecasts To 2027 – Disease Indication

8.1       Overview

8.2       Global Prenatal and Newborn Genetic Testing Market Share By Disease Indication 2018 & 2027 (%)

8.3       Cystic Fibrosis

8.3.1        Overview

8.3.2        Cystic Fibrosis Market Revenue and Forecast to 2027 (US$ Mn)

8.4       Sickle Cell Anemia

8.4.1        Overview

8.4.2        Sickle Cell Anemia Market Revenue and Forecast to 2027 (US$ Mn)

8.5       Down Syndrome

8.5.1        Overview

8.5.2        Downs Syndrome Market Revenue and Forecast to 2027 (US$ Mn)

8.6       Phenylketonuria

8.6.1        Overview

8.6.2        Phenylketonuria Market Revenue and Forecast to 2027 (US$ Mn)

8.7       Other Diseases

8.7.1        Overview

8.7.2        Other Diseases Market Revenue and Forecast to 2027 (US$ Mn)

9.             Prenatal And Newborn Genetic Testing Market Analysis And Forecasts To 2027 – End User

9.1       Overview

9.2       Global Prenatal And Newborn Genetic Testing Market Share By End User 2018 & 2027 (%)

9.3       Hospitals & Clinics

9.3.1        Overview

9.3.2        Global Hospitals & Clinics Market Revenue and Forecasts to 2027 (US$ Mn)

9.4       Diagnostics Centers

9.4.1        Overview

9.4.2        Diagnostics Centers Market Revenue and Forecast to 2027 (US$ Mn)

9.5       Other End Users

9.5.1        Overview

9.5.2        Global Other End Users Market Revenue and Forecasts to 2027 (US$ Mn)

10.          Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 – Geographical Analysis

10.1    North America Prenatal And Newborn Genetic Testing Market

10.1.1     Overview

10.1.2     North America Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.3     North America Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.1.3.1    North America Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.3.2    North America Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.4     North America Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027,  By Disease Indication (US$ Mn)

10.1.5     North America Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.2    North America Prenatal and Newborn Genetic Testing Market Revenue And Forecasts To 2027,  By Country (%)

10.3    US Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

10.3.1     US Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.1.1    US Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.3.1.1.1    US Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.3.1.1.2    US Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.3.1.2    US Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

10.3.1.3    US Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.4    Canada Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

10.4.1     Canada Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.1.1    Canada Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.4.1.1.1    Canada Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.4.1.1.2    Canada Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.4.1.2    Canada Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

10.4.1.3    Canada Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.5    Mexico Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

10.5.1     Mexico Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.5.1.1    Mexico Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.5.1.1.1    Mexico Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.5.1.1.2    Mexico Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.5.1.2    Mexico Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication  (US$ Mn)

10.5.1.3    Mexico Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.6    Europe Prenatal And Newborn Genetic Testing Market

10.6.1     Overview

10.6.2     Europe Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027 (US$ Mn)

10.6.3     Europe Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product  (US$ Mn)

10.6.3.1    Europe Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.6.3.2    Europe Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.6.4     Europe Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

10.6.5     Europe Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User  (US$ Mn)

10.6.6     Europe Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027, By Country (%)

10.6.7     Germany Prenatal and Newborn Genetic Testing Market

10.6.7.1    Germany Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.6.7.2    Germany Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.6.7.2.1    Germany Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.6.7.2.2    Germany Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.6.7.3    Germany Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

10.6.7.4    Germany Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.6.8     UK Prenatal and Newborn Genetic Testing Market

10.6.8.1    UK Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.6.8.2    UK Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.6.8.2.1    UK Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.6.8.2.2    UK Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.6.8.3    UK Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

10.6.8.4    UK Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.6.9     France Prenatal and Newborn Genetic Testing Market

10.6.9.1    France Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.6.9.2    France Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.6.9.2.1    France Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.6.9.2.2    France Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.6.9.3    France Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication  (US$ Mn)

10.6.9.4    France Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.6.10   Spain Prenatal and Newborn Genetic Testing Market

10.6.10.1 Spain Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.6.10.2 Spain Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.6.10.2.1 Spain Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.6.10.2.2 Spain Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.6.10.3 Spain Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication  (US$ Mn)

10.6.10.4 Spain Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.6.11   Italy Prenatal and Newborn Genetic Testing Market

10.6.11.1 Italy Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.6.11.2 Italy Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.6.11.2.1 Italy Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.6.11.2.2 Italy Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.6.11.3 Italy Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication  (US$ Mn)

10.6.11.4 Italy Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.7    Asia Pacific Prenatal And Newborn Genetic Testing Market

10.7.1     Overview

10.7.2     Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.7.3     Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.7.3.1    Asia Pacific Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.7.3.2    Asia Pacific Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.7.4     Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

10.7.5     Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.8    Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027, By Country (%)

10.8.1     China Prenatal And Newborn Genetic Testing Market

10.8.1.1    China Prenatal And New born Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.8.1.2    China Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.8.1.2.1    China Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.8.1.2.2    China Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.8.1.3    China Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication  (US$ Mn)

10.8.1.4    China Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.8.2     Japan Prenatal And New born Genetic Testing Market

10.8.2.1    Japan Prenatal And New Born Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.8.2.2    Japan Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.8.2.2.1    Japan Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.8.2.2.2    Japan Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.8.2.3    Japan Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication  (US$ Mn)

10.8.2.4    Japan Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.8.3     India Prenatal And New born Genetic Testing Market

10.8.3.1    India Prenatal And New born Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.8.3.2    India Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.8.3.2.1    India Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.8.3.2.2    India Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.8.3.3    India Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication  (US$ Mn)

10.8.3.4    India Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.8.4     Australia Prenatal And New Born Genetic Testing Market

10.8.4.1    Australia Prenatal And Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.8.4.2    Australia Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.8.4.2.1    Australia Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.8.4.2.2    Australia Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.8.4.3    Australia Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

10.8.4.4    Australia Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.8.5     South Korea Prenatal And Newborn Genetic Testing Market

10.8.5.1    South Korea Prenatal And Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.8.5.2    South Korea Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.8.5.2.1    South Korea Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.8.5.2.2    South Korea Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.8.5.3    South Korea Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

10.8.5.4    South Korea Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.9    Middle East And Africa Prenatal And Newborn Genetic Testing Market

10.9.1     Overview

10.9.2     Middle East & Africa Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027,  By Product (US$ Mn)

10.9.2.1    Middle East & Africa Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.9.2.2    Middle East & Africa Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.9.3     Middle East & Africa Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027,  By Disease Indication (US$ Mn)

10.9.4     Middle East & Africa Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027,  By End User (US$ Mn)

10.10 Middle East & Africa Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027, By Country (%)

10.10.1   UAE Prenatal And New born Genetic Testing Market

10.10.1.1 UAE Prenatal And Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.10.1.2 UAE Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.10.1.2.1 UAE Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.10.1.2.2 UAE Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.10.1.3 UAE Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication  (US$ Mn)

10.10.1.4 UAE Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.10.2   Saudi Arabia Prenatal And Newborn Genetic Testing Market

10.10.2.1 Saudi Arabia Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.10.2.2 Saudi Arabia Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.10.2.2.1 Saudi Arabia Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.10.2.2.2 Saudi Arabia Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.10.2.3 Saudi Arabia Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

10.10.2.4 Saudi Arabia Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.10.3   South Africa Prenatal And Newborn Genetic Testing Market

10.10.3.1 South Africa Prenatal And New born Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.10.3.2 South Africa Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.10.3.2.1 South Africa Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.10.3.2.2 South Africa Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.10.3.3 South Africa Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

10.10.3.4 South Africa Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.11 South And Central America Prenatal And Newborn Genetic Testing Market

10.11.1   Overview

10.11.2   South and Central America Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027 (US$ Mn)

10.11.3   South and Central America Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.11.3.1 South and Central America Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.11.3.2 South and Central America Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.11.4   South and Central America Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

10.11.5   South and Central America Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.11.6   South and Central America Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027, By Country (%)

10.11.7   Brazil Prenatal and Newborn Genetic Testing Market

10.11.7.1 Brazil Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.11.7.2 Brazil Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.11.7.2.1 Brazil Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.11.7.2.2 Brazil Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.11.7.3 Brazil Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication  (US$ Mn)

10.11.7.4 Brazil Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.11.8   Argentina Prenatal and Newborn Genetic Testing Market

10.11.8.1 Argentina Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.11.8.2 Argentina Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.11.8.2.1 Argentina Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.11.8.2.2 Argentina Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.11.8.3 Argentina Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

10.11.8.4 Argentina Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.          Prenatal And Newborn Genetic Testing Market – Industry Landscape

11.1    Overview

11.2    Comparative Company Analysis

11.3    Growth Strategies Done by the Companies in the Market, (%)

11.4    Organic Developments

11.4.1     Overview

11.5    Inorganic Developments

11.5.1     Overview

12.          Prenatal And Newborn Genetic Testing Market–Key Company Profiles

12.1    Abbott

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Financial Overview

12.1.4     Product Portfolio

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2    Quest Diagnostics Incorporated

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Financial Overview

12.2.4     Product Portfolio

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3    Ravgen

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Financial Overview

12.3.4     Product Portfolio

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4    F. Hoffmann-La Roche Ltd.

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Financial Overview

12.4.4     Product Portfolio

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5    Qiagen N.V.

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Financial Overview

12.5.4     Product Portfolio

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6    Bio-Rad Laboratories, Inc.

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Financial Information

12.6.4     Product Portfolio

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7    Berry Gene

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Financial Overview

12.7.4     Product Portfolio

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8    PerkinElmer, Inc.

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Financial Overview

12.8.4     Product Portfolio

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9    Natera, Inc.

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Financial Overview

12.9.4     Product Portfolio

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10 Laboratory Corporation Of America Holdings (Sequenom)

12.10.1   Key Facts

12.10.2   Business Description

12.10.3   Financial Overview

12.10.4   Product Portfolio

12.10.5   SWOT Analysis

12.10.6   Key Developments

12.11 Illumina, Inc.

12.11.1   Key Facts

12.11.2   Business Description

12.11.3   Financial Overview

12.11.4   Product Portfolio

12.11.5   SWOT Analysis

12.11.6   Key Developments

13.          Appendix

13.1    About The Insight Partners

13.2    Glossary Of Terms


LIST OF TABLES

Table 1.             North America Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product  (US$ Mn)

Table 2.             North America Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 3.             North America Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 4.             North America Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

Table 5.             North America Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)

Table 6.             US Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 7.             US Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 8.             US Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 9.             US Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication  (US$ Mn)

Table 10.          US Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)

Table 11.          Canada Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 12.          Canada Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 13.          Canada Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 14.          Canada Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

Table 15.          Canada Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)

Table 16.          Mexico Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 17.          Mexico Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 18.          Mexico Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 19.          Mexico Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

Table 20.          Mexico Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)

Table 21.          Europe Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 22.          Europe Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 23.          Europe Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 24.          Europe Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

Table 25.          Europe Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)

Table 26.          Germany Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 27.          Germany Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 28.          Germany Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 29.          Germany Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

Table 30.          Germany Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)

Table 31.          UK Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 32.          UK Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 33.          UK Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 34.          UK Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication  (US$ Mn)

Table 35.          UK Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)

Table 36.          France Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 37.          France Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 38.          France Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 39.          France Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

Table 40.          France Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)

Table 41.          Spain Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 42.          Spain Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 43.          Spain Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 44.          Spain Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

Table 45.          Spain Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)

Table 46.          Italy Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 47.          Italy Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 48.          Italy Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 49.          Italy Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

Table 50.          Italy Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)

Table 51.          Asia Pacific Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product  (US$ Mn)

Table 52.          Asia Pacific Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 53.          Asia Pacific Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 54.          Asia Pacific Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

Table 55.          Asia Pacific Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User  (US$ Mn)

Table 56.          China Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 57.          China Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 58.          China Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 59.          China Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

Table 60.          China Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)

Table 61.          Japan Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 62.          Japan Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 63.          Japan Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 64.          Japan Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

Table 65.          Japan Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)

Table 66.          India Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 67.          India Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 68.          India Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 69.          India Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

Table 70.          India Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)

Table 71.          Australia Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 72.          Australia Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 73.          Australia Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 74.          Australia Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

Table 75.          Australia Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)

Table 76.          South Korea Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product  (US$ Mn)

Table 77.          South Korea Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 78.          South Korea Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 79.          South Korea Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

Table 80.          South Korea Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User  (US$ Mn)

Table 81.          Middle East & Africa Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027,  By Product (US$ Mn)

Table 82.          Middle East & Africa Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 83.          Middle East & Africa Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 84.          Middle East & Africa Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027,  By Disease Indication (US$ Mn)

Table 85.          Middle East & Africa Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027,  By End User (US$ Mn)

Table 86.          UAE Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 87.          UAE Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 88.          UAE Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 89.          UAE Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

Table 90.          UAE Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)

Table 91.          Saudi Arabia Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product  (US$ Mn)

Table 92.          Saudi Arabia Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 93.          Saudi Arabia Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 94.          Saudi Arabia Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

Table 95.          Saudi Arabia Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User  (US$ Mn)

Table 96.          South Africa Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product  (US$ Mn)

Table 97.          South Africa Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 98.          South Africa Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 99.          South Africa Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

Table 100.       South Africa Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User  (US$ Mn)

Table 101.       South And Central America Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027,  By Product (US$ Mn)

Table 102.       South And Central America Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 103.       South And Central America Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 104.       South And Central America Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027,  By Disease Indication (US$ Mn)

Table 105.       South And Central America Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027,  By End User (US$ Mn)

Table 106.       Brazil Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 107.       Brazil Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 108.       Brazil Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 109.       Brazil Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

Table 110.       Brazil Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)

Table 111.       Argentina Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

Table 112.       Argentina Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 113.       Argentina Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 114.       Argentina Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

Table 115.       Argentina Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User  (US$ Mn)

Table 116.       Organic Developments Done By Companies

Table 117.       Inorganic Developments Done By Companies

Table 118.       Glossary Of Terms, Prenatal And Newborn Genetic Testing Market

 

LIST OF FIGURES

Figure 1.           Prenatal And Newborn Genetic Testing Market Segmentation

Figure 2.           Prenatal And Newborn Genetic Testing Segmentation, By Region

Figure 3.           Asia Pacific Prenatal And Newborn Genetic Testing Market, Revenue (US$ Mn), 2018 & 2027

Figure 4.           Global Prenatal And Newborn Genetic Testing Market By Product, Market Share (%), 2018

Figure 5.           Global Prenatal And Newborn Genetic Testing Market By Disease Indication, Market Share (%), 2018

Figure 6.           Global Prenatal And Newborn Genetic Testing Market By End User, Market Share (%), 2018

Figure 7.           North America PEST Analysis

Figure 8.           Europe PEST Analysis

Figure 9.           Asia Pacific PEST Analysis

Figure 10.        Middle East & Africa PEST Analysis

Figure 11.        South & Central America PEST Analysis

Figure 12.        Prenatal And Newborn Genetic Testing Market Impact Analysis of Driver And Restraints

Figure 13.        Global Prenatal And Newborn Genetic Testing Market – Revenue Forecasts And Analysis – 2018- 2027

Figure 14.        Global Prenatal And Newborn Genetic Testing Market – By Geography Forecasts And Analysis – 2018- 2027

Figure 15.        Global Prenatal and Newborn Genetic Testing Market Share By Product 2018 & 2027 (%)

Figure 16.        Diagnostic Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 17.        Spectrophotometer Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 18.        Polymerase Chain Reaction Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 19.        Fluorescence In-Situ Hybridization Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 20.        Array Comparative Genomic Hybridization Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 21.        Screening Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 22.        Maternal Serum Screening Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 23.        Chorionic Villus Sampling Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 24.        Amniocentesis Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 25.        Non-Invasive Prenatal Testing Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 26.        Global Prenatal and Newborn Genetic Testing Market Share By Disease Indication 2018 & 2027 (%)

Figure 27.        Cystic Fibrosis Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 28.        Sickle Cell Anemia Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 29.        Downs Syndrome Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 30.        Phenylketonuria Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 31.        Other Diseases Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 32.        Global Prenatal and Newborn Genetic Testing Market Share By End User 2018 & 2027 (%)

Figure 33.        Global Hospitals & Clinics Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 34.        Diagnostics Centers Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 35.        Global Other End User Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 36.        North America Prenatal And Newborn Genetic Testing Market REVENUE Overview, By Country, 2018 (US$ MN)

Figure 37.        North America Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 38.        North America Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027,  By Country (%)

Figure 39.        US Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 40.        Canada Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 41.        Mexico Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 42.        Europe Prenatal And Newborn Genetic Testing Market Revenue Overview, By Country (2018) (US$ Mn)

Figure 43.        Europe Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 44.        Europe Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027, By Country (%)

Figure 45.        Germany Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 46.        UK Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 47.        France Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 48.        Spain Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 49.        Italy Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 50.        Asia Pacific Prenatal And Newborn Genetic Testing Market REVENUE Overview, By Country, 2018 (US$ MN)

Figure 51.        Asia Pacific Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 52.        Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027, By Country (%)

Figure 53.        China Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 54.        Japan Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 55.        India Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 56.        Australia Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 57.        South Korea Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 58.        Middle East And Africa Prenatal And Newborn Genetic Testing Market Revenue Overview, By Country  (2018) (US$ Mn)

Figure 59.        Middle East & Africa Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027,  By Country (%)

Figure 60.        UAE Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 61.        Saudi Arabia Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 62.        South Africa Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 63.        South And Central America Prenatal And Newborn Genetic Testing Market Revenue Overview, By Country (2018) (US$ Mn)

Figure 64.        South And Central America Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 65.        South and Central America Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027,  By Country (%)

Figure 66.        Brazil Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 67.        Argentina Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 68.        Comparative Company Analysis

Figure 69.        Growth Strategies Done by the Companies in the Market, (%)

 

The List of Companies

  1. Abbott
  2. Quest Diagnostics Incorporated
  3. Ravgen
  4. Bio-Rad Laboratories, Inc.
  5. Illumina, Inc.
  6. F. Hoffmann La-Roche Ltd.
  7. Qiagen
  8. Berry Gene
  9. PerkinElmer, Inc.
  10. Natera, Inc.
  11. Laboratory Corporation of America Holdings (Sequenom)
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the prenatal and newborn genetic testing market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the global prenatal and newborn genetic testing market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.